The website you are visiting is protected and accelerated by Incapsula. Your computer may have been infected by malware and ...

Cardinal Health reported an increase in revenue for two of its segments, while the departure of Optimum impacted its ...

Mizuho Securities analyst Steven Valiquette has reiterated their bullish stance on CAH stock, giving a Buy rating yesterday.Invest with ...

Jan 30 (Reuters) - Drug distributor Cardinal Health on Thursday raised its fiscal 2025 adjusted profit forecast as strong demand for costly specialty medicines and branded drugs drove sales at its ...

Cardinal Health warned Thursday that if President Donald Trump follows through with threatened tariffs next month, higher prices for some of the company's products will follow. Trump is set to ...

Morgan Stanley analyst Erin Wright maintained a Buy rating on Cardinal Health (CAH – Research Report) today and set a price target of $136.00.

Robust demand across its pharmaceutical and specialty solutions segment was the impetus behind Cardinal Health raising its fiscal 2025 enterprise guidance, said Jason Hollar, CEO of Cardinal ...

Dublin City Schools is officially withdrawing from an agreement with Cardinal Health to purchase a vacant office building, Superintendent John Marschhausen told board members at a meeting Monday ...

Citi analyst Daniel Grosslight increased the price target for Cardinal Health (NYSE:CAH) shares to $130 from the previous ...

Cardinal Health, Inc. operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals ...

Cardinal Health Inc (NYSE:CAH). shares have reached an unprecedented peak, with the stock hitting an all-time high of $130.1.

Cardinal Health CEO Jason Hollar recounted the company's "nice run" at the nation's largest annual healthcare industry conference. Cardinal Health Inc. raised its earnings outlook for fiscal 2025 ...